Linus Health Unveils Innovative Digital Solutions for Early Dementia Detection at AAIC 2025
Linus Health is at the forefront of revolutionizing brain health with innovative digital solutions, and it's set to present groundbreaking research at the Alzheimer's Association International Conference (AAIC) 2025, running from July 27 to 31 in Toronto and virtually. This year, the company will host two oral presentations and display eight posters, all dedicated to advancing early detection and personalized approaches in addressing cognitive impairments.
At Booth #1219, Linus Health will showcase its AI-driven digital cognitive assessment tools, along with previews of enhancements to their life sciences research platform. This year's conference is significant as it aligns with Linus Health's broader vision of transforming brain health by enabling proactive support to be as accessible as possible, directly empowering individuals in their cognitive health journey.
Linus Health CEO and Co-Founder, Dr. David Bates, emphasizes the importance of their work: "The studies we are presenting at AAIC 2025 represent the next wave of translational science in brain health. By combining validated digital tools with AI, we're enabling earlier and more accurate detection of mild cognitive impairment, Alzheimer's disease, and related dementias. Our goal is to expand access to proactive brain health support through solutions that can be accessed from home."
Among the critical research topics Linus Health will present are:
This focus on quantifying cognitive testing processes will mark a significant step towards a more neuropsychological approach in brain health assessment, aiming to enhance the efficacy of both clinical trials and everyday patient care.
Key Sessions Include:
Linus Health's commitment to advancing brain health through actionable scientific insights and innovation is evident in their approach to enhancing early detection of cognitive disorders. As they continue to develop tools for both clinical and research settings, the company looks forward to networking and discussing their impactful research with attendees at AAIC 2025.
For more insights on Linus Health's contributions at the conference or to schedule discussions with their team, visit linushealth.com/aaic-2025.
Based in Boston, Linus Health is a digital health company dedicated to transforming how we understand and manage brain health globally. By harnessing AI, clinical expertise, and state-of-the-art neuroscience, the aim is to realize a future where individuals can lead longer, happier, and healthier lives with enhanced cognitive health. The digital cognitive assessment platform developed delivers reliable means for early detection, supports healthcare providers with actionable insights, and empowers individuals to take charge of their cognitive health journey. For more information about their proactive brain health solutions, visit linushealth.com or follow them on LinkedIn.
At Booth #1219, Linus Health will showcase its AI-driven digital cognitive assessment tools, along with previews of enhancements to their life sciences research platform. This year's conference is significant as it aligns with Linus Health's broader vision of transforming brain health by enabling proactive support to be as accessible as possible, directly empowering individuals in their cognitive health journey.
Linus Health CEO and Co-Founder, Dr. David Bates, emphasizes the importance of their work: "The studies we are presenting at AAIC 2025 represent the next wave of translational science in brain health. By combining validated digital tools with AI, we're enabling earlier and more accurate detection of mild cognitive impairment, Alzheimer's disease, and related dementias. Our goal is to expand access to proactive brain health support through solutions that can be accessed from home."
Key Highlights from Linus Health at AAIC 2025
Among the critical research topics Linus Health will present are:
- - Machine Learning-Enabled Digital Cognitive Assessment: Dr. Ali Jannati, Director of Cognitive Science at Linus Health, will showcase findings related to concurrent detection of cognitive impairment and amyloid-beta PET status. This machine learning model is designed to streamline trial pre-screening, effectively identifying participants eligible for Alzheimer's disease trials while reducing their burden during the recruitment process.
- - Multi-Modal AI Models: The company will explore how combining digital assessments with various biomarkers and features derived from voice and stylus input can enhance the detection of cognitive impairment and predict AD pathology, thereby reinforcing the utility of their assessments.
- - Personalization and Engagement: The exploration of novel methods for creating personalized health recommendations based on individual values and preferences illustrates Linus Health's commitment to tailored cognitive health solutions.
- - Validation of Digital Cognitive Metrics: Dr. David Libon, a scientific advisor for Linus Health, will present findings on the clinical relevance of digital metrics in assessing cognitive performance and their relationships with traditional neuropsychological tests.
This focus on quantifying cognitive testing processes will mark a significant step towards a more neuropsychological approach in brain health assessment, aiming to enhance the efficacy of both clinical trials and everyday patient care.
Upcoming Presentations and Sessions
Key Sessions Include:
- - July 26: Oral presentations discussing abbreviated digital assessments and separation of neurocognitive versus motor disabilities.
- - July 28-30: Focused sessions exploring machine learning's role in improving recruitment for AD clinical trials, the correlation between digital and traditional assessments, and the validation of multi-modal metrics.
Linus Health's commitment to advancing brain health through actionable scientific insights and innovation is evident in their approach to enhancing early detection of cognitive disorders. As they continue to develop tools for both clinical and research settings, the company looks forward to networking and discussing their impactful research with attendees at AAIC 2025.
For more insights on Linus Health's contributions at the conference or to schedule discussions with their team, visit linushealth.com/aaic-2025.
About Linus Health
Based in Boston, Linus Health is a digital health company dedicated to transforming how we understand and manage brain health globally. By harnessing AI, clinical expertise, and state-of-the-art neuroscience, the aim is to realize a future where individuals can lead longer, happier, and healthier lives with enhanced cognitive health. The digital cognitive assessment platform developed delivers reliable means for early detection, supports healthcare providers with actionable insights, and empowers individuals to take charge of their cognitive health journey. For more information about their proactive brain health solutions, visit linushealth.com or follow them on LinkedIn.
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.